Prof. MD. Nihan Alkis Reviews

During my wife's high-risk pregnancy, Prof. Alkis managed her essential thrombocythemia with such precision that she avoided blood thinners until the final month. Our healthy twins were born without complications, and my wife's condition remains stable two years later under Prof. Alkis's continued care.

As a 67-year-old retired ship captain, I was preparing my affairs when diagnosed with myelodysplastic syndrome. Prof. Alkis's personalized hypomethylating agent therapy reversed my transfusion dependency completely. I've now sailed the Mediterranean twice since treatment, something I never thought possible.

As a 22-year-old competitive cyclist, my unexplained fatigue was dismissed as overtraining until Prof. Alkis discovered I had paroxysmal nocturnal hemoglobinuria. Her targeted treatment plan not only saved my life but allowed me to return to professional racing within a year, winning two national championships post-recovery.

My 8-year-old daughter's mysterious bruising was initially misdiagnosed as playground injuries. Prof. Alkis recognized the pattern of immune thrombocytopenic purpura immediately. Her gentle approach with pediatric patients and innovative steroid-sparing protocol gave us our vibrant child back without the side effects we feared.

Our family's genetic bleeding disorder affected three generations until Prof. Alkis identified it as a rare form of Glanzmann thrombasthenia. She coordinated care across five family members simultaneously, creating individual management plans that transformed how we live with this condition.

I collapsed during a business conference in Bursa with no medical history. Prof. Alkis diagnosed acute promyelocytic leukemia within hours and initiated emergency treatment that prevented fatal bleeding. Her rapid response turned a medical catastrophe into a curable condition.

My teenage son's 'growing pains' were actually sickle cell crisis manifestations that local doctors missed. Prof. Alkis implemented hydroxyurea therapy and comprehensive pain management that reduced his hospitalizations from monthly to zero in six months.

As a 45-year-old chef, I ignored persistent itching until liver enzymes revealed polycythemia vera. Prof. Alkis's therapeutic phlebotomy schedule and medication regimen allowed me to continue working while managing the condition, even during busy restaurant seasons.

My husband's rare cold agglutinin disease meant winter was life-threatening. Prof. Alkis developed a seasonal treatment protocol using rituximab that lets him enjoy outdoor activities year-round for the first time in a decade.

After failed treatments elsewhere for aplastic anemia, Prof. Alkis recommended an unrelated donor transplant when I was 58. Her meticulous preparation and post-transplant care resulted in full engraftment with minimal graft-versus-host disease.

My daughter's mysterious fevers and joint pain were finally diagnosed as systemic mastocytosis by Prof. Alkis after three years of searching. The targeted therapy she prescribed stopped the anaphylactic episodes that had hospitalized her repeatedly.

As a 33-year-old with beta thalassemia major, I'd accepted lifelong transfusions until Prof. Alkis enrolled me in a gene therapy trial she was overseeing. Two years later, I'm transfusion-independent and training for my first marathon.

During routine surgery, I developed heparin-induced thrombocytopenia. Prof. Alkis was consulted emergently and switched my anticoagulation within hours, preventing the bilateral leg amputations my surgeon warned were likely.

My grandmother's Waldenström macroglobulinemia caused such severe neuropathy she couldn't hold her great-grandchildren. Prof. Alkis's combination therapy reduced the IgM levels by 80%, restoring her hand function enough to knit blankets for each new family member.

As an expatriate teacher in Turkey, I developed unexplained pancytopenia. Prof. Alkis discovered it was triggered by a rare medication reaction to a local antibiotic. Her detective work solved the mystery when multiple other specialists had recommended bone marrow transplantation unnecessarily.